387 related articles for article (PubMed ID: 31691261)
21. Graves' orbitopathy, idiopathic orbital inflammatory pseudotumor and Epstein-Barr virus infection: a serological and molecular study.
Leo M; Maggi F; Dottore GR; Casini G; Mazzetti P; Pistello M; Sellari-Franceschini S; Nardi M; Vitti P; Marcocci C; Marinò M
J Endocrinol Invest; 2017 May; 40(5):499-503. PubMed ID: 27987077
[TBL] [Abstract][Full Text] [Related]
22. The challenge of orbital decompression in a patient with multiple autoimmune diseases and graves' orbitopathy: a case report and review of literature.
Sellari-Franceschini S; Bartalena L; Seccia V
Orbit; 2010 Feb; 29(1):48-50. PubMed ID: 20302412
[TBL] [Abstract][Full Text] [Related]
23. ORBITAL PSEUDOTUMOR CAN MIMIC GRAVES' OPHTHALMOPATHY.
Stanciu M; Popa FL; Totoian IG; Bera LG
Acta Endocrinol (Buchar); 2016; 12(3):344-348. PubMed ID: 31149112
[TBL] [Abstract][Full Text] [Related]
24. [Graves' orbitopathy].
Eckstein A; Esser J
Klin Monbl Augenheilkd; 2011 May; 228(5):432-8. PubMed ID: 21534176
[TBL] [Abstract][Full Text] [Related]
25. Ocular Hypertension, Glaucoma or Compressive Neuropathy in Patient with Active TED.
Stoyanova NS; Konareva-Kostianeva MI; Mitkova-Hristova VT
Folia Med (Plovdiv); 2020 Jun; 62(2):418-423. PubMed ID: 32666771
[TBL] [Abstract][Full Text] [Related]
26. Asymmetric Graves' Orbitopathy.
Panagiotou G; Perros P
Front Endocrinol (Lausanne); 2020; 11():611845. PubMed ID: 33391188
[TBL] [Abstract][Full Text] [Related]
27. [Graves' ophthalmopathy].
Eckstein A; Esser J
Internist (Berl); 2010 May; 51(5):584, 586-8, 590-2, passim. PubMed ID: 20383481
[TBL] [Abstract][Full Text] [Related]
28. [Autoantibodies, immunoglobulins and cytokine profile in patients with graves' disease and Graves' orbitopathy].
Sviridenko NY; Bessmertnaya EG; Belovalova IM; Mikheenkov AA; Sheremeta MS; Nikankina LV; Malysheva NM
Probl Endokrinol (Mosk); 2020 Oct; 66(5):15-23. PubMed ID: 33369369
[TBL] [Abstract][Full Text] [Related]
29. Pediatric Graves' orbitopathy: a multicentre study.
Ionescu IC; van Trotsenburg PAS; Paridaens D; Tanck M; Mooij CF; Cagienard E; Kalmann R; Pakdel F; van der Meeren S; Saeed P
Acta Ophthalmol; 2022 Sep; 100(6):e1340-e1348. PubMed ID: 34951116
[TBL] [Abstract][Full Text] [Related]
30. Computer aided volumetric assessment of orbital structures in patients with Graves' orbitopathy: correlation with serum thyroid antiperoxidase antibodies and disease activity.
Paniagua L; Bande MF; Abalo-Lojo JM; Gonzalez F
Int Ophthalmol; 2023 Sep; 43(9):3377-3384. PubMed ID: 37338774
[TBL] [Abstract][Full Text] [Related]
31. Graves' orbitopathy: extraocular muscle/total orbit area ratio is positively related to the Clinical Activity Score.
Le Moli R; Pluchino A; Muscia V; Regalbuto C; Luciani B; Squatrito S; Vigneri R
Eur J Ophthalmol; 2012; 22(3):301-8. PubMed ID: 21786273
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of multifocal visual evoked potentials in patients with Graves' orbitopathy and subclinical optic nerve involvement.
Pérez-Rico C; Rodríguez-González N; Arévalo-Serrano J; Blanco R
Doc Ophthalmol; 2012 Aug; 125(1):11-9. PubMed ID: 22581376
[TBL] [Abstract][Full Text] [Related]
33. Orbital lymphoma masquerading as thyroid-associated orbitopathy.
Leo M; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2009 Sep; 94(9):3155-6. PubMed ID: 19734444
[No Abstract] [Full Text] [Related]
34. Epidemiology, Natural History, Risk Factors, and Prevention of Graves' Orbitopathy.
Bartalena L; Piantanida E; Gallo D; Lai A; Tanda ML
Front Endocrinol (Lausanne); 2020; 11():615993. PubMed ID: 33329408
[TBL] [Abstract][Full Text] [Related]
35. Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease.
Moshkelgosha S; Verhasselt HL; Masetti G; Covelli D; Biscarini F; Horstmann M; Daser A; Westendorf AM; Jesenek C; Philipp S; Diaz-Cano S; Banga JP; Michael D; Plummer S; Marchesi JR; Eckstein A; Ludgate M; Berchner-Pfannschmidt U;
Microbiome; 2021 Feb; 9(1):45. PubMed ID: 33593429
[TBL] [Abstract][Full Text] [Related]
36. Prevention of graves' orbitopathy: early diagnosis of thyroid-associated orbitopathy in Graves' disease.
Mourits MP
Orbit; 2008; 27(6):399-400. PubMed ID: 19085291
[No Abstract] [Full Text] [Related]
37. Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.
Perros P; Hegedüs L; Bartalena L; Marcocci C; Kahaly GJ; Baldeschi L; Salvi M; Lazarus JH; Eckstein A; Pitz S; Boboridis K; Anagnostis P; Ayvaz G; Boschi A; Brix TH; Currò N; Konuk O; Marinò M; Mitchell AL; Stankovic B; Törüner FB; von Arx G; Zarković M; Wiersinga WM
Orphanet J Rare Dis; 2017 Apr; 12(1):72. PubMed ID: 28427469
[TBL] [Abstract][Full Text] [Related]
38. Superior ophthalmic vein thrombosis: A rare complication of Graves' orbitopathy.
Sorrentino D; Taubenslag KJ; Bodily LM; Duncan K; Stefko T; Yu JY
Orbit; 2018 Jun; 37(3):175-178. PubMed ID: 29053044
[TBL] [Abstract][Full Text] [Related]
39. Graded decompression of orbital fat and wall in patients with Graves' orbitopathy.
Lee KH; Jang SY; Lee SY; Yoon JS
Korean J Ophthalmol; 2014 Feb; 28(1):1-11. PubMed ID: 24505195
[TBL] [Abstract][Full Text] [Related]
40. Idiopathic sclerosing orbital inflammation and active Graves' orbitopathy.
Detorakis ET; Haniotis V; Mavrikakis I; Drakonaki EE
Ophthalmic Plast Reconstr Surg; 2014; 30(1):77-9. PubMed ID: 24398501
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
